XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Business Segments | 6 Months Ended
--- | ---
Dec. 31, 2023
Business Segments |
Business Segments | 11. Business Segments We evaluate performance and allocate resources, based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development. The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein. We evaluate performance of our segments based on Adjusted EBITDA. We calculate Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency (gains) losses, net and (e) certain items that we consider to be unusual, non-operational or non-recurring. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months |  | Six Months
For the Periods Ended December 31 |  | 2023 |  | 2022 |  | 2023 |  | 2022
Net sales |  |  |  |  |  |  |  |  |  |  |  |
Animal Health | ​ | $ | 173,104 | ​ | $ | 163,803 | ​ | $ | 333,634 | ​ | $ | 318,662
Mineral Nutrition | ​ |  | 61,347 | ​ |  | 61,644 | ​ |  | 117,373 | ​ |  | 121,290
Performance Products | ​ |  | 15,492 | ​ |  | 19,199 | ​ |  | 30,285 | ​ |  | 37,215
Total segments | ​ | $ | 249,943 | ​ | $ | 244,646 | ​ | $ | 481,292 | ​ | $ | 477,167
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 7,348 | ​ | $ | 6,934 | ​ | $ | 14,697 | ​ | $ | 13,845
Mineral Nutrition | ​ |  | 660 | ​ |  | 659 | ​ |  | 1,306 | ​ |  | 1,314
Performance Products | ​ |  | 433 | ​ |  | 453 | ​ |  | 859 | ​ |  | 895
Total segments | ​ | $ | 8,441 | ​ | $ | 8,046 | ​ | $ | 16,862 | ​ | $ | 16,054
Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 39,299 | ​ | $ | 37,059 | ​ | $ | 67,793 | ​ | $ | 64,023
Mineral Nutrition | ​ |  | 3,507 | ​ |  | 4,399 | ​ |  | 6,388 | ​ |  | 9,696
Performance Products | ​ |  | 817 | ​ |  | 2,292 | ​ |  | 2,226 | ​ |  | 4,656
Total segments | ​ | $ | 43,623 | ​ | $ | 43,750 | ​ | $ | 76,407 | ​ | $ | 78,375
Reconciliation of income (loss) before income taxes to Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income (loss) before income taxes | ​ | $ | 3,565 | ​ | $ | 12,109 | ​ | $ | (8,414) | ​ | $ | 17,526
Interest expense, net | ​ |  | 4,659 | ​ |  | 3,884 | ​ |  | 9,223 | ​ |  | 6,951
Depreciation and amortization – Total segments | ​ |  | 8,441 | ​ |  | 8,046 | ​ |  | 16,862 | ​ |  | 16,054
Depreciation and amortization – Corporate | ​ |  | 469 | ​ |  | 453 | ​ |  | 919 | ​ |  | 895
Corporate costs | ​ | ​ | 14,171 | ​ | ​ | 12,838 | ​ | ​ | 28,304 | ​ | ​ | 25,329
Acquisition-related cost of goods sold | ​ | ​ | 310 | ​ | ​ | — | ​ | ​ | 310 | ​ | ​ | —
Pension settlement cost | ​ | ​ | 249 | ​ | ​ | — | ​ | ​ | 10,674 | ​ | ​ | —
Brazil employment taxes | ​ | ​ | 4,202 | ​ | ​ | — | ​ | ​ | 4,202 | ​ | ​ | —
Stock-based compensation | ​ | ​ | 80 | ​ | ​ | — | ​ | ​ | 161 | ​ | ​ | —
Environmental remediation costs | ​ | ​ | — | ​ | ​ | 6,569 | ​ | ​ | — | ​ | ​ | 6,569
Foreign currency losses (gains), net | ​ |  | 7,477 | ​ |  | (149) | ​ |  | 14,166 | ​ |  | 5,051
Adjusted EBITDA – Total segments | ​ | $ | 43,623 | ​ | $ | 43,750 | ​ | $ | 76,407 | ​ | $ | 78,375
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, |  | June 30,
As of |  | 2023 |  | 2023
Identifiable assets |  | ​ |  |  | ​ |
Animal Health | ​ | $ | 694,383 | ​ | $ | 698,522
Mineral Nutrition | ​ |  | 71,755 | ​ |  | 75,814
Performance Products | ​ |  | 48,879 | ​ |  | 49,678
Total segments | ​ |  | 815,017 | ​ |  | 824,014
Corporate | ​ |  | 157,691 | ​ |  | 147,383
Total | ​ | $ | 972,708 | ​ | $ | 971,397
​ The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax-related assets and certain other assets.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//280/tableOfContent Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration